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Background: Endosaphenous laser ablation is used in the treatment of great saphenous vein insufficiency with various
methods, with and without surgical interruption. However, its mode of action and indications are not yet clear.
Methods: To verify the mode of action of endosaphenous laser ablation by duplex ultrasound (DUS) follow-up, with the
support of histologic observations of eight cases, 44 of 182 affected limbs (CEAPC2 to C6) were selected for intravenous
laser ablation of the great saphenous vein. Saphenofemoral junction incompetence was treated by surgical interruption.
An 808-nm diode laser (Eufoton, Trieste, Italy) was used (variable pull-back velocity, 1 to 3 mm/s; power, 12 to 15 W;
energy, 30 to 40 J/cm). In eight limbs the venous fragments were studied under light microscopy at 5 minutes and
after 1 and 2 months. In 44 limbs DUS and clinical examinations were performed from 7 days to 1, 2, 6, and 12
months.
Results: Variously organized thrombi containing necrotic inclusions and patent areas were observed in the vein lumen.
Neither neovascularization nor thrombus extension were detected at the groin by DUS examination. Progressive venous
diameter decrease and thrombus fibrotic transformation up to the hypotrophic venous disappearance at 12 months were
followed up (P< .00001). Not occluded (18.8%), recanalized short segments (22.7%), two entirely recanalized saphenous
veins with varicose recurrence (4.5%), and postoperative phlebitis (13.6%) were observed. Nonocclusions and phlebitis
prevailed in the larger veins (P < .05).
Conclusion: The healing process is based on vein thrombosis, fibrosis, and venous atrophy. Saphenofemoral interruption
makes venous occlusion easier and prevents potential thrombotic complications and recurrence by recanalization. DUS
monitoring makes possible to follow-up the thrombus involution and perform early retreatment. The 808-nm endosa-
phenous laser should be mainly applied to veins of <10 mm in diameter. ( J Vasc Surg 2008;48:1262-71.)Endosaphenous laser ablation (ELA) for superficial ve-
nous insufficiency and varicose veins of the lower limbs has
been performed using various devices, wavelengths, tech-
niques, and methods. The observations and results de-
scribed in the literature cannot be easily compared. Most
articles report satisfactory short- and medium-term clinical
results. However, some major complications and causes for
potential recurrence, such as phlebitis of the great saphe-
nous vein (GSV), thrombosis ascending into the deep
veins, GSV recanalizations, and nonocclusions, have been
described.1-4
In some surgical centers ELA is combined with the
surgical interruption of the saphenofemoral junction (SFJ)
to prevent deep vein thrombosis and potential recurrence
due to insufficient occlusion or recanalization; however,
most authors perform ELA alone. The clinical value of
adjunctive proximal GSV ligation still is unknown.5
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1262Some of the changes produced by ELA in the incom-
petent GSV were investigated by means of duplex ultra-
sound (DUS) examinations6-8 and by a few histologic
studies.9,10 These demonstrated that intravenous laser
irradiation is followed by blood vaporization, venous
wall shrinking, thrombosis, and fibrosis. The physics,
engineering, and tissue interactions of lasers and their
clinical applications are exhaustively described in a recent
textbook.11 More recent reports have shown that a high
energy (80 J/cm) is necessary to obtain complete GSV
occlusion.12
In our previous histologic study, the immediate GSV
changes after laser irradiation were observed under light
microscopy.13 We found that a 808-nm wavelength mainly
acts on the blood, with mild thermal damage to the inner
venous wall, and leads to optimal immediate results in
GSVs of 9.7 mm in diameter. In none of the histologic
samples studied was immediate venous occlusion observed.
Some of the details concerning our conclusions were re-
cently confirmed by an experimental study on amathematic
model.14
It has been recently pointed out that the exact anatomic
result that correlates with improved long-term clinical out-
comes has not been scientifically proved and that at present,
anatomic success should be defined as successful ablation of
the target vein, as demonstrated by the complete lack of
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the whole treated segment.15
METHODS
A technology assessment study by postoperative DUS
imaging supported by histologic observations under light
microscopy was performed to observe GSV changes after
ELA treatment by a 808-nm diode laser combined with
surgical SFJ interruption during a 12-month follow-up.
Between September 2002 and June 2005, 1135 limbs
underwent noninvasive examinations for venous disease, of
which 182 limbs with primary GSV insufficiency and vari-
cose veins of the lower limbs were classified according to
CEAP (C2 to C6) and to the Venous Clinical Severity
Score (0 to 3). The 182 limbs underwent ELA on the basis
of recommended I and II levels of investigation.15
The following criteria were prospectively adopted: in-
competence of SFJ and GSV with a reflux time of 1
second16-18 studied by the Valsalva maneuver and distal
compression, and a postexercise refilling time of 20 sec-
onds,19 respectively, measured by DUS examination with
7.5-MHz high-resolution probe and photoplethysmogra-
phy. Patients with acute or previous phlebitis, multiple
saphenous aneurysms, congenital malformations, deep vein
insufficiency, post-thrombotic varicose veins of the lower
limbs, and major comorbidities were excluded. Early and
limited SFJ and GSV incompetence, characterized by a
reflux time of 1 second, simple valvular annulus dilata-
tion, and still normal valve cusps, were also excluded and
underwent repairs.20 The DUS follow-up study included
44 limbs at C2 to C4 and 182 limbs with a Venous Clinical
Severity Score of 0 to 2. The general characteristics of the
patients followed up are summarized in Table I.
The preoperative GSV diameter (average, 10.3 mm;
range, 4-18mm) was measured by DUS cross scanning at 2
cm below the subterminal valve, at a mean distance of
approximately 7 cm from the SFJ. Further diameter mea-
surements were taken on the whole GSV length to detect
the more dilated segments.
The procedures were performed with the patient in the
horizontal position. The disposable, 600-m diameter op-
tical fiber was introduced through a 3- to 5-mm skin
incision below the knee, up to the SFJ; or directly from the
incision at the groin and pushed distally down to the upper
third of the leg. The progression or pullback of the optical
fiber was controlled by transillumination, and no intraop-
Table I. Distribution of eight great saphenous venous
fragments studied by light microscopy
Gender Age
Limbs,
No. Segments Side Watt
M 10 Min 31 Single 18 GSV 40 Left 24 12-15
F 34 Max 83 Bilateral
13
Access
SV 4
Right 20 12
Total 44 Mean 50 Total 44 Total 44 Total 44 Mean 14.4
GSV, Great saphenous vein; SV, saphenous vein.erative DUS guide was necessary.The SFJ was detected by transillumination, sectioned
flush to the common femoral vein, and tributary veins were
interrupted in 43 of 44 limbs at the beginning of the
procedure by an 8- to 15-mm skin incision at the groin
according to the traditional surgical technique, save for the
small-sized surgical wound. No surgical interruption was
performed on one limb, which had competent terminal and
subterminal valves at the SFJ and reflux beginning approx-
imately at 3 cm below. ELA of the incompetent GSV was
performed by a small incision below the knee and by
transillumination monitoring up to 2 cm below the subter-
minal valve. The circulatory effect of SFJ competence is
comparable with what is achieved by surgical interruption,
therefore the limb was also included into the study.
An 808-nm diode laser (Eufoton, Trieste, Italy) was
used; the wavelength was chosen on the basis of its simul-
taneous selectivity for oxyhemoglobin, deoxyhemoglobin,
and myoglobin.11 In accordance with other authors, con-
tinuous energy emission was preferred.8,10 A 12- to 15-W
power emission was applied in 44 veins, with a variable
optic fiber pullback velocity of 1 to 3mm/s. The power and
pullback velocity were subjected to variations in an inverse
relationship with the venous diameter variations to obtain
an approximately homogenous fluence. A mean energy of
30 to 40 J/cm of venous length was applied.
Incompetent perforators and peripheral varices were
treated by intravenous laser or selective surgical treatment
with a mini-invasive surgical approach. The clinical and
DUS follow-up is still in progress, and the results are not
included in the present study. The procedure, which ex-
tended to perforators and to all the peripheral varices,
required subarachnoid anesthesia. Local anesthesia was
used in the limbs undergoing more limited surgery. No
tumescent anesthesia was used to prevent injuries to the
surrounding tissues, and a satisfactory immediate decrease
of the venous diameter was obtained thanks to the surgical
interruption of the SFJ as demonstrated in the previous
study,13 except for the limb with competent SFJ.
An intraoperative sterile bandage was applied progres-
sively during the fiber pullback maneuver to reduce the
blood volume, thrombus size, and the risk of phlebitis. A
class I (30-mm Hg) graduated compression stocking was
applied at the end of the procedure and worn for 5 days.
Antithrombotic pharmacologic prophylaxis with 0.2 mL of
calcium heparin was administered immediately before sur-
gery and 12 hours later in patients undergoing subarach-
noid anesthesia or with additional factors of thrombotic
risk. No prophylaxis was applied in patients who were
treated with local anesthesia.
In eight limbs that underwent ELA, histologic obser-
vations were performed under light microscopy on proxi-
mal GSV fragments. In three cases the proximal GSV
fragment, about 3 cm long, was taken immediately at the
end of ELA and before the end of the procedure. The
immediate thermal damage to blood and inner tissues of
the venous wall was studied. Venous fragments were not
subjected to preservative perfusion in order to observe the
blood transformation in the vessel lumen.
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follow-up underwent the same treatment on the second
limb and gave their written consent for an investigational
surgical procedure (biopsy) on the limb previously treated
with ELA. TwoGSV fragments about 3 cm longwere taken
from the first treated limb after the DUS control at 30 days.
Three fragments were taken after the DUS control at 60
days, in correspondence with the proximal GSV stump that
previously underwent ELA through a small skin incision at
approximately 7 cm below the groin. The samples were
fixed in 75% alcohol, embedded in paraffin, cross-sectioned,
and stainedwith hematoxylin and eosin,Weigert-VanGieson,
and phosphotungstic acid-hematoxylin. Their distribution is
reported in Table II.
Thrombus formation, its evolution, and the venous
wall regressive alterations from ELA thermal damage were
studied. The presence of blood cells, macrophages, plate-
lets, fibrin, collagen and elastic fibers, fibrocytes, neovascu-
larization, thrombus detachment, Zahn’s lines, which are
the typical expressions of spontaneous thrombus progres-
sive aggregation, and inflammatory cells, which can be
found in cases with spontaneous phlebitis,21 were studied
in the vein lumen. The involution after thermal damage to
the intima and inner media, the thickness, and sclerosis of
the media were studied in the venous wall.
In 44 cases the DUS examination was performed at the
thigh at different levels after 7 days and 1, 2, 6 and 12
months. The first level corresponded to the common fem-
oral vein and the proximal saphenous stump to verify the
surgical outcome of ligation and the presence of small
tortuous vessels connected with the GSV stump as a result
of neovascularization.22 The second observation was per-
formed at the level of the distal saphenous stump, at ap-
proximately 7 cm below the interrupted SFJ, to measure
the venous diameter at the distal GSV stump where the
structure and development of the thrombus could be stud-
ied. Further scans were performed on the whole length of
the occluded GSV. Echogenic variations of the venous
content and wall were followed up. All the procedures were
performed by the same experienced surgeon, and the220
DUS investigations by the same experienced operator.
Early failures were interpreted as technical failures,
whereas late failures were interpreted as the result of recan-
alization.15 The correlations between preoperative and
postoperative diameters, postoperative GSV phlebitis, non-
occlusions, and recanalizations were studied.
Clinical signs of skin burns and nerve injury were inves-
Table II. Distribution of 44 great saphenous veins follow
12 months
Gender Age Limbs, No. F
M 1 Min 42 Single 6 GS
F 7 Max 67 Bilateral 1 Ac
Mean 51 Total 8 To
GSV, Great saphenous vein; SV, saphenous vein.tigated. The correlations were analyzed by Student t test,with one degree of freedom, performed on the mean val-
ues, and the 2 test.
RESULTS
Histology. In three samples that did not belong to the
DUS follow-up, taken immediately after ELA treatment, it
was possible to observe the early transformation of the
vessel lumen content as clumped erythrocytes (Fig 1),
necrotic inclusions, amorphous substance, and large empty
areas from blood vaporization (Fig 2). Necrosis of the
intima and thermal damage to the inner media were
observed in the venous wall of the three samples (Figs 1
and 2).
In two cases belonging to the DUS follow-up, the
occluded venous segments were taken 1 month later, im-
mediately after DUS imaging and during the procedure on
the second limb. Homogeneous hypotrophic tissue thin-
ning and sclerosis of the media were observed in the venous
wall. The vessel lumen was occupied by typical thrombi
(Fig 3) that were mainly characterized by platelet-fibrin
units21 and small new capillaries (Fig 4). The thrombus
appeared to be attached to the venous wall, with a more
advanced fibrotic organization in the peripheral circumfer-
ence, and in one sample, large empty areas covered with
Fig 1. A cross section of a great saphenous vein distal stump taken
7 cm below the groin immediately after surgical interruption and
endosaphenous laser ablation shows clumped erythrocytes and
necrotic fragments visible in the vein lumen. Circular necrotic
thermal damage to the intima and inner media can be seen in
correspondence with a necrotic fragment (black arrow). Hematox-
ylin and eosin staining; original magnification 100.
by duplex ultrasound examination from 7 days to
ents Side Watt Biopsy, No.
Left 5 12-15 Intra-op 3
V 1 Right 3 12 30 days 2
Total 8 Mean 60 days 3ed up
ragm
V 7
cess S
tal 8normal endothelium (Fig 4).
magnification 30.
tion 25.
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more advanced venous wall hypotrophy and central fibrotic
organization of the thrombus with necrotic inclusions in its
various parts were found (Fig 5). Neither signs of progres-
Fig 4. Detail from Fig 3 of a patent peripheral area in the throm-
bus covered with endothelium shows a peripheral organization
process of the thrombus and small new vessels in the thrombus
structure (black arrow). Hematoxylin and eosin staining; original
magnification 30.
Fig 5. Cross section of a great saphenous vein distal stump taken
7 cm below the groin 60 days after surgical interruption and
endosaphenous laser ablation (ELA) shows more advanced hypo-
trophic thinning of the venous wall, with marked sclerosis of the
media. Thrombus is partially attached to the venous wall, with
fibrotic organization more advanced in the middle section and
necrotic inclusions (black arrows). Inflammatory cells are visible in
the peripheral section due to post-ELA phlebitis (white arrow).
(Compare with Fig 8, which shows the duplex ultrasound imaging
of the same sample.) Phosphotungstic acid-hematoxylin staining;
original magnification 25.Fig 3. A cross section of a great saphenous vein distal stump taken
7 mm below the groin 30 days after surgical interruption and
endosaphenous laser ablation shows symmetric thinning of the
venous wall, with sclerosis of the media. Thrombus is attached to
the venous wall, with more advanced fibrous organization in the
peripheral circumference than in the center. Two patent peripheral
areas probably corresponding to a partial occlusion or early recan-
alization (black arrows) are visible, as is early hypotrophy of the
venous wall. (Compare with the duplex ultrasound imaging of the
same sample in Fig 6.) Hematoxylin and eosin staining; originalFig 2. A cross section of a great saphenous vein distal stump
taken 7 cm below the groin immediately after surgical interrup-
tion and endosaphenous laser ablation shows blood transforma-
tion into amorphous substance, with necrotic tissue residues
and large empty areas corresponding to thermal blood vapor-
ization. Circular necrosis of the intima and thermal damage
to the inner media is shown (black arrow) along with asymmet-
ric thinning and thickening of the venous wall, with sclerosis of
the media. Hematoxylin and eosin staining; original magnifica-sive aggregation (Zahn’s lines) nor inflammatory cells were
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months, in which a postoperative phlebitis developed (pre-
operative diameter, 16 mm), some inflammatory cells were
present in the peripheral part of the thrombus (Fig 5).
Duplex ultrasound. Seven days after the procedure,
none of the 44 GSVs (100%) that underwent the DUS
follow-up examination were compressible, they contained
hypoechogenic material, and they were free from blood
flow (fresh thrombus). Venous diameters were significantly
decreased vs the preoperative measurements (mean, 3.07
mm; range, 2.3-12 mm; P .00001). Some short (3 to 10
cm), not occluded, compressible, partially or totally patent
venous segments with mild reflux were found in eight limbs
(18.18%).
The DUS investigation of the five segments examined
before biopsy was performed on the occasion of ELA of the
second limb, at 30 and 60 days, made it possible to compare
the histologic finding with the DUS imaging of the treated
GSV at the same level.
One month after the procedure, the venous wall was
represented by a thinned hypoechogenic peripheral circle
surrounding the thrombus (Figs 6 and 7). In 52% of the
cases the thrombus appeared to consist of a hyperechogenic
circle, corresponding to peripheral fibrosis, and a hypo-
echogenic central area, corresponding to an early organiza-
tion (mixed thrombus; Fig 6). The comparison between
Fig 3 and Fig 6 from the same patient, who underwent
simultaneous biopsy of the previously treated limb and
Fig 6. Duplex ultrasound cross-scanning (7.5-MHz probe) of a
great saphenous vein distal stump performed 7 cm below the groin
30 days after surgical interruption and endosaphenous laser abla-
tion immediately before histologic observation (Figs 3 and 4)
shows thinning of the venous wall (hypoechogenic peripheral
circle). In 52% of the cases, the thrombus is represented by a
hyperechogenic circle, corresponding to a peripheral fibrosis, with
a hypoechogenic middle section corresponding to early organiza-
tion (mixed thrombus). No flowwas detected in the patent luminal
area.ELA of the second limb after 30 days, helps clarify theinterpretation of the DUS imaging. The thrombi in 43%
appeared to be fully hyperechogenic (fibrotic thrombus;
Fig 7). The difference was not statistically significant. Only
in two cases (4.5%) was the thrombus still fully hypoecho-
genic. A further venous diameter decrease (mean, 3.73
mm; range, 2-11 mm) was observed (P  .00001). The
number of not occluded venous segments (n 8, 18.18%)
did not change.
Two months after ELA, a higher number of segments
developed a completely hyperechogenic intraluminal con-
tent (fibrotic thrombus, 54%), such as the one shown in Fig
7, whereas the others (46%) maintained a mixed aspect,
such as in Fig 6 (compare Figs 5 and 8, from the same
patient, 2 months after the procedure). This difference was
not statistically significant. A mean decrease of the venous
diameter of 4.54 mm (range, 2-10 mm) was observed (P
.00001). The same number of not occluded segments (n
8; 18.18%) was found. Three segments withmild reflux and
limited residual varicose veins underwent primary assisted
ablation by echo-guided foam sclerotherapy, but five ap-
peared to be not relevant under DUS evaluation and did
not have any further treatment.
Six months later, the venous content appeared to be
fully hyperechogenic (fibrotic thrombus) in 75% of the
cases (P  .00001), and the mean decrease in venous
diameter was 5.83 mm (range, 1.7-7 mm; P .00001; Fig
8). In 10 limbs (22.7%), some new short patent and incom-
petent segments were detected, and all underwent primary
assisted ablation by echo-guided foam sclerotherapy. In
one case the GSV was no longer visible in its anatomic site
at 6 months.
At the end of the month 12, 35 of 44 GSVs (77%; P
Fig 7. Duplex ultrasound cross-scanning (7.5-MHz probe) of a
great saphenous vein distal stump performed 7 cm below the groin,
30 days after surgical interruption and endosaphenous laser abla-
tion, shows thinning of the venous wall (hypoechogenic peripheral
circle). In 43% of the cases, the thrombus is entirely hyperecho-
genic. The image corresponds to a complete early fibrotic organi-
zation..00001) were no longer detectable by DUS observation in
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present with fibrous thrombi in the vein lumen. The mean
venous diameter decrease was 7.45 mm (range, 1.5-4.2
mm; P  .05). The mean GSV diameter decrease and the
thrombi structural transformation during 12 months are
shown in Figs 10 and 11, respectively.
Most not occluded segments observed during the first
2 months belonged to GSVs with a preoperative diameter
Fig 8. Duplex ultrasound cross-scanning (7.5-MHz probe) of a
great saphenous vein distal stump performed 7 cm below the groin
60 days after surgical interruption, and endosaphenous laser abla-
tion immediately before histologic observation (Fig 5), shows
persistence of the venous wall imaging (hypoechogenic peripheral
circle). In 75% of the limbs at 6 months (P .00001), the venous
content appeared to be entirely hyperechogenic (fibrotic thrombus).
Fig 9. Duplex ultrasound cross-scanning (7.5-MHz probe) of a
great saphenous vein 12 months after surgical interruption and
endosaphenous ablation shows the end of the atrophic process: the
great saphenous vein is not detected in the normal anatomic site.of10mm (mean, 11.8; range, 8-16mm; P .05), but nosignificant relationship between the recanalized segments
at 6 months and the preoperative diameter was found.
Recurrent GSV reflux due to complete GSV recanali-
zation was observed in two limbs (4.5%). They underwent
secondary ablation (retreatment) by surgical revision and
stripping.
No tortuous small vessels connected with the saphe-
nous stump by neovascularization were found up to 12
months after flush ligation. A large residual tributary vein of
4 mm in diameter directly connected to the common
femoral vein was found in one case.
Clinical review. In seven limbs (13.6%), a painful
postoperative phlebitis at the thigh occurred in GSVs of
10 mm in diameter (average, 12.3; range, 12-13.7 mm;
P  .001) a few days after the treatment. The cases were
resolved after a couple of weeks with anticoagulant, anti-
inflammatory drug therapy, and elastic compression. No
skin burns or symptoms from nerve injury were observed.
Symptoms from recurrent venous insufficiency were
present in two limbs (4.5%) at 12 months.
DISCUSSION
Our previous histologic work13 demonstrated that the
optimal thermal tissue damage in the venous wall was
obtained in veins of9.7 mm in diameter by the procedure
described. However, we noticed that ELA combined with
SFJ interruption does not produce any immediate GSV
occlusion.
Owing to obvious ethical and technical reasons, it was
impossible to find more patients available for multiple
biopsies and perform a more extensive study at different
GSV levels by histology and DUS imaging. Therefore, we
could use our few histologic findings only as a support for
Fig 10. Diagram of the progressive mean decrease of the great
saphenous vein (GSV) diameter after surgical interruption and
endosaphenous laser ablation during a 12-month follow-up. The
duplex ultrasound examination used a 7.5-MHz probe. (Level of
statistical significance, P  .01; 2 test). Mean diameter decrease:
at 1 week, 3.07 mm (range, 2.3-12 mm; P .00001); at 1 month,
3.73 mm (range 2-11 mm; P  .00001); at 2 months, 4.54 mm
(range, 2-10 mm; P  .00001; at 6 months, 5.83 mm (range,
1.7-7mm; P .00001), and at 12months in nine persistent GSVs,
7.45 mm (range, 1.5-4.2 mm; P  .05). At 12 months, 35 of 44
GSV (77%) had disappeared (P  .00001).the DUS follow-up study. The three histologic samples
13.99
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vascular lumen content, which was mainly represented by
the products of the early thermal damage to the blood and
the inner venous wall. Such transformations correspond to
those necessary for the beginning of thrombus formation,
as described in the previous study.13
The two samples studied by DUS imaging and taken 1
month after ELA, and the three samples taken and exam-
ined after 2 months, allowed us to verify the changes in the
thrombus and venous wall structure, which subsequently
led to fibrotic transformation and GSV occlusion.
The early-organized thrombi were very similar to the
spontaneous ones except for the presence of necrotic inclu-
sions from the blood cells and inner venous tissues, and the
absence of inflammatory cells and the Zahn lines indicating
progressive thrombus stratification.21 Inflammatory cells
did not seem to be usually present in ELA-produced
thrombi except for the cases with post-treatment GSV
phlebitis (Fig 5).
The comparison between the histologic findings and
DUS imaging performed on the same patients facilitated
the interpretation of the DUS follow-up of the 44 limbs.
From these results, we can now state that DUS examination
makes it possible to follow-up the thrombus and venous
wall transformation and obtain some prognostic data con-
cerning the healing process, and that a stable fibrotic occlu-
sion can be expected within 6months in most of the treated
veins and definitive GSV atrophy will occur approximately
after 12 months in most cases.
Completely not occluded or partially occluded short
GSV segments, 5 cm in length, were observed in 8 limbs
from the first week and during the first 6 months. The
significant relationship found with the preoperative GSV
Fig 11. Diagram of the great saphenous vein thrombi t
laser ablation during a 12-month follow-up by duplex
endosaphenous laser ablation, there was 100% hypoec
presence of mixed (squares) and hyperechogenic (fibro
Prevalence of fresh thrombi at 1 week was P .00001 an
saphenous veins disappeared vs nine persisting (100% fib
level of statistical significance, 0.05; standard deviation,diameters denotes that a large vein size is related to a lessertendency to occlusion. Perhaps the ELA procedure was
performed by using energy that was insufficient in relation
to the more extensive surface of the vessel lumen of more
dilated segments12 and should be interpreted as technical
failure.15 The high rate (18.18%) of early nonoccluded
short venous segments, even if they were not hemodynam-
ically significant, has recently led us to increase the energy
delivered.
The presence of large empty areas covered with endo-
thelium, which are visible in the peripheral part of the
histologic samples studied after 1 and 2 months, should be
interpreted as the result of an incomplete occlusion, as was
observed in eight limbs during the 1- and 2-month follow-
up. The presence of small capillaries in the thickness of the
thrombus structure represents a physiologic component of
its evolution potentially leading to recanalization, as more
frequently happens after superficial and deep vein throm-
bosis,23,24 and seems to give a satisfactory explanation for
the appearance of recanalized segments after 6 months.
This tendency was also observed in the past after sclerother-
apy and was considered the major cause of recurrence.24-26
More recently, recanalization of ELA-produced thrombus
obtained with a 980-nm diode laser was reported by other
authors.27 Therefore, we can be conclude that recanaliza-
tion after ELA does not depend on the technique used but
is due to the physiologic evolution of the thrombus.
Even though the ELA-produced thrombi appeared to
be mainly tending to stable fibrosis than to recanalization,
in comparison with the spontaneous ones and those after
sclerotherapy, we were prompted to prevent the potential
extension of the recanalization process and the worsening
of the patient’s conditions in the future by performing
primary assisted ablation by sclerotherapy of the recanalized
ormation after surgical interruption and endosaphenous
sound examination (7.5-MHz probe). At 7 days after
nic (fresh) thrombi (triangles). The difference in the
rombi (circles) at 30 and 60 days was not significant.
months was P .00001. At 12 months, 35 of 44 great
P  .00001). (Student t test with 1 degree of freedom;
1; 95% confidence interval, 4.1339.ransf
ultra
hoge
us) th
d at 6
rous;segments. This extra treatment did not modify the experi-
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canalized segments corresponded to the level of the DUS
controls that were performed immediately below the GSV
interruption. Furthermore, painful, postoperative phlebitis
at the thigh appeared to be significantly related to preop-
erative diameters of 10 mm; therefore, ELA has to be
considered more effective and safer in smaller veins.
The absence of skin burns and paresthesias, even with-
out the use of tumescent anesthesia or skin protection,
confirms that the energy delivered by a 808-nm diode laser,
approximately 30 to 40 J/cm of venous length, leads to
immediate optimal results. However, a more stable and
complete GSV occlusion should be obtained by delivering
higher energy.
Despite the low energy applied, in seven cases the
postoperative stage was unsatisfactory due to painful phle-
bitis, and in many other cases, the occluded GSV remained
palpable for1 month. Histology, DUS, and clinical eval-
uation show the indubitable presence of laser-produced
thrombi in the treated GSVs by the above method. Patients
who presented with phlebitis after treatment required spe-
cific drug therapy. In cases with increasing severity, surgical
revision and antibiotic therapy may also be necessary.28
Both uncompleted surgery of the SFJ and neovasculariza-
tion causedby the surgical injury to the venouswall22,29-33 are
commonly considered to be the main factors responsible
for recurrence. Neovascularization seems to be more fre-
quently produced by the transformation of thrombi, heal-
ing wounds, and hematomas.22,34-36 From these facts it
could be assumed that neovascularization at the groin can
be due to the combination of a large-sized surgical incision
and the venous wall injury. The absence of neovasculariza-
tion in our patients could be explained by the small size of
the surgical incisions. Therefore, the risk of potential neo-
vascularization should not be taken into to great account
for justifying the sparing of incompetent SFJs.
Now that something more is known about the mode of
action of ELA, a comparison of the procedure with sclero-
therapy rather than with surgery seems to be preferable. At
the same time, it does not seem appropriate to define the
simple ELA of incompetent GSVs as a standard surgical
procedure.37
Surgical interruption of the SFJ makes it possible to
eliminate the reflux, leads to the decrease of venous diam-
eter and blood volume, facilitates GSV thrombosis in its
proximal part,38 and results in venous occlusion with a low
dose of energy. It also represents the safest defense against
the spontaneous tendency to recanalization by thrombus
neovascularization and the best prevention for its potential
extension into the deep veins, which is a predictable com-
plication after ELA of both the great and short saphenous
veins.1,2,4,39 It can also be added that information concern-
ing some potential damage from SFJ interruption, the fate
of the SFJ after ELA, or the real advantage of sparing could
not be found in the literature until now. It seems obvious
that no indication for performing the SFJ interruption was
found in patients with competent or repairable proximal
saphenous valves.Finally, it must be stressed that our findings are strictly
related to limbs that undergo combined SFJ surgical inter-
ruption and ELA of incompetent GSV by an 808-nm
wavelength. It can be supposed that our findings are not
applicable to different methods and devices used for the
endovascular thermal ablation of incompetent GSV.
CONCLUSION
On the basis of findings from our previous and present
studies, we can state that the ELA mode of action by a
808-nm diode laser in combination with SFJ surgical inter-
ruption is represented by the following sequence: blood
necrosis and vaporization, necrosis of the intima and inner
media, shrinking of the inner media due to collagen and
myoglobin retraction, thrombosis, fibrosis, thrombus and
venous wall hypotrophic involution, and atrophy. This
process requires approximately 12 months. We can con-
clude that the mechanism for the final healing of the
incompetent GSVs is based on the thrombus formation and
its fibrotic organization, which is followed by atrophy in-
volving the venous wall. Therefore, ELA of incompetent
GSVs can be defined as physical sclerotherapy.
The ELA-produced thrombi are structurally similar to
spontaneous thrombi, except for the presence of necrotic
inclusions and the simultaneous development over the
entire venous length, which is documented by the absence
of Zahn’s lines of stratification.21
The DUS images obtained during the follow-up ap-
peared to correspond to the thrombus and venous wall
transformation and its atrophic involution. The various
steps of the process should be followed by DUS examina-
tion for appropriate management of each clinical case and
to apply primary assisted ablation by some early extra
treatment of the incompetent segments.
The best results were obtained in veins of 10 mm in
diameter, whereas large-sized veins have a greater tendency
to no occlusion and phlebitis. The quality of the medium-
term clinical outcome depends mainly on the venous diam-
eter; surgical interruption of SFJ and stripping seem to be
more recommendable in larger GSVs. Recanalization of the
occluded GSVs by ELA does not appear to be related to the
venous size or to the technique used, but mainly depends
on a typical characteristic of the thrombus.
A low energy of approximately 30 to 40 J/cm seems to
be appropriate to limit postoperative GSV phlebitis and
other side effects on the skin and nerves; however, a more
satisfactory venous occlusion could be obtained by deliver-
ing a higher energy.
Neovascularization seems to be avoided by a mini-
mally invasive surgical approach for SFJ interruption,
and sparing is not justified by scientific evidence at
present. A correctly performed interruption seems rec-
ommendable for obtaining the decrease of vein caliber
and blood volume, delivering lower energy, facilitating
thrombosis, preventing the potential recurrence by
thrombus recanalization and, above all, the potential
extension of thrombi into the deep veins.
JOURNAL OF VASCULAR SURGERY
November 20081270 Corcos et alThe 808-nm ELA technique should be adjusted to
each clinical variation, and the procedure cannot be
standardized. ELA alone should be applied mainly in
limbs with a competent SFJ. At the present time, ELA is
an interesting alternative for treating selected patients,
but does not seem to be the final solution for the
treatment of all patients with varicose veins of the lower
limbs and incompetent GSVs.
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